Determinación de los niveles de lípidos en sangre

Referencias

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment PanelIII). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
(Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
2. De Backer G, Ambrosioni E, Borch-Johnsen K, et al; Third Joint Task Force of Europeanand Other Societies on Cardiovascular Disease Prevention in Clinical Practice.European guidelines on cardiovascular disease prevention in clinical practice:Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003;24(17):1601-1610.
3. Warnick GR, Nakajima K. Fasting versus nonfasting triglycerides: implications for laboratory measurements. Clin Chem. 2008;54(1):14-16.
4. Schaefer EJ, Audelin MC, McNamara JR, et al. Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease. Am J Cardiol. 2001;88(10):1129-1133.
5. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299-308.
6. Eberly LE, Stamler J, Neaton JD; Multiple Risk Factor Intervention Trial Research
Group. Relation of triglyceride levels, fasting and nonfasting, to fatal and
nonfatal coronary heart disease. Arch Intern Med. 2003;163(9):1077-1083.
7. Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118(20):2047-2056.
8. Branchi A, Torri A, Berra C, Colombo E, Sommariva D. Changes in serum triglyceridesand high-density lipoprotein concentration and composition after a low-fat mixed meal: effects of gender and insulin resistance.Intern Emerg Med.2006;1(4):287-295.
9. Mora S, Rifai N, Buring JE, Ridker PM. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation. 2008;118(10):993-1001.
10. Di Angelantonio E, Sarwar N, Perry P, et al; Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993-2000.
11. Craig SR, Amin RV, Russell DW, Paradise NF. Blood cholesterol screening influenceof fasting state on cholesterol results and management decisions. J GenIntern Med. 2000;15(6):395-399.
12. Wilder LB, Bachorik PS, Finney CA, Moy TF, Becker DM. The effect of fastingstatus on the determination of low-density and high-density lipoprotein cholesterol.Am J Med. 1995;99(4):374-377.
13. Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronaryheart disease: 10,158 incident cases among 262,525 participants in 29 Westernprospective studies. Circulation. 2007;115(4):450-458.
14. Nordestgaard BG, Langsted A, Freiberg JJ. Nonfasting hyperlipidemia and cardiovasculardisease. Curr Drug Targets. 2009;10(4):328-335.
15. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting comparedwith nonfasting triglycerides and risk of cardiovascular events in women. JAMA.2007;298(3):309-316.
16. Dubois C, Armand M, Azais-Braesco V, et al. Effects of moderate amounts ofemulsified dietary fat on postprandial lipemia and lipoproteins in normolipidemicadults. Am J Clin Nutr. 1994;60(3):374-382.
17. Ridker PM. Fasting versus nonfasting triglycerides and the prediction of cardiovascularrisk: do we need to revisit the oral triglyceride tolerance test? Clin Chem.2008;54(1):11-13.